Overview

Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration

Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of hydromorphone hydrochloride by intrathecal administration using a programmable implantable pump.
Phase:
Phase 3
Details
Lead Sponsor:
Mallinckrodt
Piramal Critical Care, Ltd.
Treatments:
Hydromorphone